{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:13:59Z","timestamp":1759482839799},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00467-018-3963-x","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T15:49:57Z","timestamp":1528127397000},"page":"777-785","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treating the idiopathic nephrotic syndrome: are steroids the answer?"],"prefix":"10.1007","volume":"34","author":[{"given":"Georges","family":"Desch\u00eanes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Dossier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"3963_CR1","unstructured":"Riley CM (1950) The effect of adrenocorticotrophic hormone on salt and water excretion in children with the nephrotic syndrome. Am J Dis Child 80:520\u2013521"},{"key":"3963_CR2","unstructured":"Barnett HL, Mc NH, Mc CW, Forman C, Rapoport M, Michie A, Barbero G (1950) The effects of ACTH and cortisone on the nephrotic syndrome. Am J Dis Child 80:519\u2013520"},{"key":"3963_CR3","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1172\/JCI102399","volume":"29","author":"JA Luetscher Jr","year":"1950","unstructured":"Luetscher JA Jr, Deming QB (1950) Treatment of nephrosis with cortisone. J Clin Invest 29:1576\u20131587","journal-title":"J Clin Invest"},{"key":"3963_CR4","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1172\/JCI105376","volume":"45","author":"KN Drummond","year":"1966","unstructured":"Drummond KN, Michael AF, Good RA, Vernier RL (1966) The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. J Clin Invest 45:620\u2013360","journal-title":"J Clin Invest"},{"key":"3963_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00431-017-2891-2","volume":"176","author":"G Deschenes","year":"2017","unstructured":"Deschenes G, Vivarelli M, Peruzzi L (2017) Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countries. Eur J Pediatr 176:647\u2013654","journal-title":"Eur J Pediatr"},{"key":"3963_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012.9","volume":"2","author":"KDIGO","year":"2012","unstructured":"KDIGO (2012) KDIGO Clinical Practice Guideline for Glomerulonephritis. Kidney Int 2:139\u2013274","journal-title":"Kidney Int"},{"key":"3963_CR7","doi-asserted-by":"publisher","unstructured":"Spencer RL, Chun LE, Hartsock MJ, Woodruff ER (2017) Glucocorticoid hormones are both a major circadian signal and major stress signal: How this shared signal contributes to a dynamic relationship between the circadian and stress systems. Front Neuroendocrinol S0091-3022(17)30103\u201330106. https:\/\/doi.org\/10.1016\/j.yfrne","DOI":"10.1016\/j.yfrne"},{"key":"3963_CR8","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1084\/jem.185.11.2033","volume":"185","author":"MS Vacchio","year":"1997","unstructured":"Vacchio MS, Ashwell JD (1997) Thymus-derived glucocorticoids regulate antigen-specific positive selection. J Exp Med 185:2033\u20132038","journal-title":"J Exp Med"},{"key":"3963_CR9","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.4049\/jimmunol.173.6.3816","volume":"173","author":"JF Purton","year":"2004","unstructured":"Purton JF, Monk JA, Liddicoat DR, Kyparissoudis K, Sakkal S, Richardson SJ, Godfrey DI, Cole TJ (2004) Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J Immunol 173:3816\u20133824","journal-title":"J Immunol"},{"key":"3963_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0162-3109(98)00034-4","volume":"40","author":"K Andreau","year":"1998","unstructured":"Andreau K, Lemaire C, Souvannavong V, Adam A (1998) Induction of apoptosis by dexamethasone in the B cell lineage. Immunopharmacology 40:67\u201376","journal-title":"Immunopharmacology"},{"key":"3963_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain DW, Cidlowski JA (2017) Immune regulation by glucocorticoids. Nat Rev Immunol 17:233\u2013247","journal-title":"Nat Rev Immunol"},{"key":"3963_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.autrev.2010.11.009","volume":"10","author":"M Zen","year":"2011","unstructured":"Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M, Ramonda R, Iaccarino L, Doria A (2011) The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 10:305\u2013310","journal-title":"Autoimmun Rev"},{"key":"3963_CR13","doi-asserted-by":"crossref","unstructured":"Pasini A, Aceto G,\u00a0Ammenti A, Ardissino G, Azzolina V, Bettinelli A,\u00a0Cama E, Cantatore S, Crisafi A, Conti G, D\u2019Agostino M, Dozza A, Edefonti A, Fede C, Groppali E, Gualeni C, Lavacchini A, Lepore M, Maringhini S, Mariotti P, Materassi M, Mencarelli F, Messina G, Negri A, Piepoli M, Ravaglia F, Simoni S, Spagnoletta L, Montini G, (2015) Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus reality. Pediatr Nephrol 30:91\u2013101","DOI":"10.1007\/s00467-014-2903-7"},{"key":"3963_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","volume":"87","author":"A Sinha","year":"2015","unstructured":"Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A (2015) Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome. Kidney Int 87:217\u2013224","journal-title":"Kidney Int"},{"key":"3963_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1681\/ASN.2012070646","volume":"24","author":"N Teeninga","year":"2013","unstructured":"Teeninga N, Kist-van Holthe JE, van Rijswijk N, de Mos NI, Hop WC, Wetzels JF, van der Heijden AJ, Nauta J (2013) Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol 24:149\u2013519","journal-title":"J Am Soc Nephrol"},{"key":"3963_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","volume":"87","author":"N Yoshikawa","year":"2015","unstructured":"Yoshikawa N, Nakanishi K, Sako M, Oba MS, Mori R, Ota E, Ishikura K, Hataya H, Honda M, Ito S, Shima Y, Kaito H, Nozu K, Nakamura H, Igarashi T, Ohashi Y, Iijima K (2015) A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment. Kidney Int 87:225\u2013232","journal-title":"Kidney Int"},{"key":"3963_CR17","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s00467-017-3579-6","volume":"32","author":"N Webb","year":"2017","unstructured":"Webb N, Wooley R, Bretell E, Cummins C, Trompeter R, Barsoum E, Ives N, investigators P (2017) Standard vs. extended course prednisolone therapy for the presenting episode of steroid sensitive nephrotic syndrome: the PREDNOS study. Pediatr Nephrol 32:1647\u20131648","journal-title":"Pediatr Nephrol"},{"key":"3963_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/FTD.0000000000000308","volume":"38","author":"N Teeninga","year":"2016","unstructured":"Teeninga N, Guan Z, Stevens J, Kist-van Holthe JE, Ackermans MT, van der Heijden AJ, van Schaik RH, van Gelder T, Nauta J (2016) Population pharmacokinetics of prednisolone in relation to clinical outcome in children with nephrotic syndrome. Ther Drug Monit 38:534\u2013545","journal-title":"Ther Drug Monit"},{"key":"3963_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s004670050344","volume":"11","author":"BK Ekka","year":"1997","unstructured":"Ekka BK, Bagga A, Srivastava RN (1997) Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndrome. Pediatr Nephrol 11:597\u2013599","journal-title":"Pediatr Nephrol"},{"key":"3963_CR20","doi-asserted-by":"publisher","unstructured":"Hahn D, Hodson EM, Willis NS, Craig JC (2015) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev, Issue3, Art N\u00b0\u00a0CD001533, 1\u2013130. https:\/\/doi.org\/10.1002\/14651858.CD001533.pub5","DOI":"10.1002\/14651858.CD001533.pub5"},{"key":"3963_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(85)91387-X","volume":"1","author":"RS Trompeter","year":"1985","unstructured":"Trompeter RS, Lloyd BW, Hicks J, White RH, Cameron JS (1985) Long-term outcome for children with minimal-change nephrotic syndrome. Lancet 1:368\u2013370","journal-title":"Lancet"},{"key":"3963_CR22","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0272-6386(03)00346-9","volume":"41","author":"M Hiraoka","year":"2003","unstructured":"Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M (2003) A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children. Am J Kidney Dis 41:1155\u20131562","journal-title":"Am J Kidney Dis"},{"key":"3963_CR23","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1681\/ASN.2005090922","volume":"17","author":"PF Hoyer","year":"2006","unstructured":"Hoyer PF, Brodeh J (2006) Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial. J Am Soc Nephrol 17:1151\u20131157","journal-title":"J Am Soc Nephrol"},{"key":"3963_CR24","doi-asserted-by":"publisher","first-page":"e018148","DOI":"10.1136\/bmjopen-2017-018148","volume":"7","author":"AM Schijvens","year":"2017","unstructured":"Schijvens AM, Dorresteijn EM, Roeleveld N, Ter Heine R, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, van de Kar N, van den Heuvel L, Schreuder MF (2017) REducing STEroids in relapsing nephrotic syndrome: the RESTERN study\u2014protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study. BMJ Open 7:e018148","journal-title":"BMJ Open"},{"key":"3963_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1056\/NEJM198202253060803","volume":"306","author":"APN","year":"1982","unstructured":"APN (1982) Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence. N Engl J Med 306:451\u2013454","journal-title":"N Engl J Med"},{"key":"3963_CR26","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","volume":"12","author":"M Vivarelli","year":"2017","unstructured":"Vivarelli M, Massella L, Ruggiero B, Emma F (2017) Minimal change disease. Clin J Am Soc Nephrol 12:332\u2013345","journal-title":"Clin J Am Soc Nephrol"},{"key":"3963_CR27","first-page":"158","volume-title":"Journ\u00e9e Parisienne de P\u00e9diatrie","author":"M Broyer","year":"1978","unstructured":"Broyer M, Kleinknecht C (1978) Traitement des n\u00e9phroses corticosensibles par la corticoth\u00e9rapie discontinue prolong\u00e9e. In: Mathieu H (ed) Journ\u00e9e Parisienne de P\u00e9diatrie. Flammarion M\u00e9decine Science, Paris, pp 158\u2013710"},{"key":"3963_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF00878359","volume":"6","author":"RN Srivastava","year":"1992","unstructured":"Srivastava RN, Vasudev AS, Bagga A, Sunderam KR (1992) Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndrome. Pediatr Nephrol 6:247\u2013250","journal-title":"Pediatr Nephrol"},{"key":"3963_CR29","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2215\/CJN.01850310","volume":"6","author":"A Gulati","year":"2011","unstructured":"Gulati A, Sinha A, Sreenivas V, Math A, Hari P, Bagga A (2011) Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol 6:63\u201369","journal-title":"Clin J Am Soc Nephrol"},{"key":"3963_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/adc.2007.116079","volume":"93","author":"AS Abeyagunawardena","year":"2008","unstructured":"Abeyagunawardena AS, Trompeter RS (2008) Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trial. Arch Dis Child 93:226\u2013228","journal-title":"Arch Dis Child"},{"key":"3963_CR31","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00467-017-3640-5","volume":"32","author":"AS Abeyagunawardena","year":"2017","unstructured":"Abeyagunawardena AS, Thalgahagoda RS, Dissanayake PV, Abeyagunawardena S, Illangasekera YA, Karunadasa UI, Trompeter RS (2017) Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndrome. Pediatr Nephrol 32:1377\u20131382","journal-title":"Pediatr Nephrol"},{"key":"3963_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s004670050308","volume":"11","author":"M Broyer","year":"1997","unstructured":"Broyer M, Terzi F, Lehnert A, Gagnadoux MF, Guest G, Niaudet P (1997) A controlled study of deflazacort in the treatment of idiopathic nephrotic syndrome. Pediatr Nephrol 11:418\u2013422","journal-title":"Pediatr Nephrol"},{"key":"3963_CR33","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.5812\/ijp.510","volume":"25","author":"R Singhal","year":"2015","unstructured":"Singhal R, Pandit S, Dhawan N (2015) Deflazacort versus prednisolone: randomized controlled trial in treatment of children with idiopathic nephrotic syndrome. Iran J Pediatr 25:e510","journal-title":"Iran J Pediatr"},{"key":"3963_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/BF02405325","volume":"36","author":"C Gennari","year":"1984","unstructured":"Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV (1984) Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Int 36:245\u2013252","journal-title":"Calcif Tissue Int"},{"key":"3963_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00467-006-0100-z","volume":"21","author":"BJ Foster","year":"2006","unstructured":"Foster BJ, Shults J, Zemel BS, Leonard MB (2006) Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol 21:973\u2013980","journal-title":"Pediatr Nephrol"},{"key":"3963_CR36","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s00467-009-1266-y","volume":"24","author":"V Leroy","year":"2009","unstructured":"Leroy V, Baudouin V, Alberti C, Guest G, Niaudet P, Loirat C, Deschenes G, Czernichow P, Simon D (2009) Growth in boys with idiopathic nephrotic syndrome on long-term cyclosporin and steroid treatment. Pediatr Nephrol 24:2393\u20132400","journal-title":"Pediatr Nephrol"},{"key":"3963_CR37","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1442-200X.2007.02429.x","volume":"49","author":"O Motoyama","year":"2007","unstructured":"Motoyama O, Iitaka K (2007) Final height in children with steroid-sensitive nephrotic syndrome. Pediatr Int 49:623\u2013625","journal-title":"Pediatr Int"},{"key":"3963_CR38","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/adc.2007.129957","volume":"95","author":"J Simmonds","year":"2010","unstructured":"Simmonds J, Grundy N, Trompeter R, Tullus K (2010) Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndrome. Arch Dis Child 95:146\u2013149","journal-title":"Arch Dis Child"},{"key":"3963_CR39","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3928\/0191-3913-19930501-03","volume":"30","author":"LD Kaye","year":"1993","unstructured":"Kaye LD, Kalenak JW, Price RL, Cunningham R (1993) Ocular implications of long-term prednisone therapy in children. J Pediatr Ophthalmol Strabismus 30:142\u2013144","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"3963_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00467-004-1579-9","volume":"20","author":"S Gulati","year":"2005","unstructured":"Gulati S, Gulati K (2005) Bone disease in nephrotic syndrome\u2014prevention is better than cure. Pediatr Nephrol 20:111\u2013112","journal-title":"Pediatr Nephrol"},{"issue":"Suppl 3","key":"3963_CR41","first-page":"205","volume":"63","author":"J Ksiazek","year":"2006","unstructured":"Ksiazek J, Niemirska A, Lipka M, Grenda R (2006) Evaluation of arterial intima-media thickness (IMT) in children with idiopathic nephrotic syndrome\u2014preliminary report. Przegl Lek 63(Suppl 3):205\u2013207","journal-title":"Przegl Lek"},{"key":"3963_CR42","first-page":"165","volume":"10","author":"M Zajaczkowska","year":"2001","unstructured":"Zajaczkowska M, Papierkowski A, Szczepanowska A, Zinkiewicz Z, Borzecka H, Zbaranska S (2001) Influence of glucocorticoid steroid therapy on gastric and duodenal mucosa and helicobacter pylori infection in children with nephrotic syndrome. Pol Merkur Lekarski 10:165\u2013167","journal-title":"Pol Merkur Lekarski"},{"key":"3963_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00467-015-3216-1","volume":"31","author":"A Upadhyay","year":"2016","unstructured":"Upadhyay A, Mishra OP, Prasad R, Upadhyay SK, Schaefer F (2016) Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal study. Pediatr Nephrol 31:233\u2013238","journal-title":"Pediatr Nephrol"},{"key":"3963_CR44","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1007\/s00467-004-1791-7","volume":"20","author":"T Ulinski","year":"2005","unstructured":"Ulinski T, Carlier-Legris A, Schlecht D, Ranchin B, Cochat P (2005) Triamcinolone acetonide: a new management of noncompliance in nephrotic children. Pediatr Nephrol 20:759\u2013762","journal-title":"Pediatr Nephrol"},{"key":"3963_CR45","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s00467-016-3400-y","volume":"31","author":"L Dehoux","year":"2016","unstructured":"Dehoux L, Hogan J, Dossier C, Fila M, Niel O, Maisin A, Macher MA, Kwon T, Baudouin V, Desch\u00eanes G (2016) Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome. Pediatr Nephrol 31:2095\u20132101","journal-title":"Pediatr Nephrol"},{"key":"3963_CR46","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.kint.2017.08.011","volume":"93","author":"MP Gruppen","year":"2018","unstructured":"Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC (2018) A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney Int 93:510\u2013518","journal-title":"Kidney Int"},{"key":"3963_CR47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5114\/ceji.2016.63122","volume":"41","author":"E Kuzma-Mroczkowska","year":"2016","unstructured":"Kuzma-Mroczkowska E, Skrzypczyk P, Panczyk-Tomaszewska M (2016) Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experience. Cent Eur J Immunol 41:243\u2013247","journal-title":"Cent Eur J Immunol"},{"key":"3963_CR48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00467-011-2006-7","volume":"27","author":"V Baudouin","year":"2012","unstructured":"Baudouin V, Alberti C, Lapeyraque AL, Bensman A, Andre JL, Broux F, Cailliez M, Decramer S, Niaudet P, Deschenes G, Jacqz-Aigrain E, Loirat C (2012) Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial. Pediatr Nephrol 27:389\u2013396","journal-title":"Pediatr Nephrol"},{"key":"3963_CR49","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/ndt\/gfh766","volume":"20","author":"I Mahmoud","year":"2005","unstructured":"Mahmoud I, Basuni F, Sabry A, El-Husseini A, Hassan N, Ahmad NS, Elbaz M, Moustafa F, Sobh M (2005) Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis. Nephrol Dial Transplant 20:735\u2013472","journal-title":"Nephrol Dial Transplant"},{"key":"3963_CR50","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2215\/CJN.01520209","volume":"4","author":"S Kengne-Wafo","year":"2009","unstructured":"Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F (2009) Risk factors for cyclosporin a nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol 4:1409\u20131416","journal-title":"Clin J Am Soc Nephrol"},{"key":"3963_CR51","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00467-011-1830-0","volume":"26","author":"S Azib","year":"2011","unstructured":"Azib S, Macher MA, Kwon T, Dechartres A, Alberti C, Loirat C, Deschenes G, Baudouin V (2011) Cyclophosphamide in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:927\u2013932","journal-title":"Pediatr Nephrol"},{"key":"3963_CR52","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s00467-011-1825-x","volume":"26","author":"A Zagury","year":"2011","unstructured":"Zagury A, de Oliveira AL, de Moraes CA, de Araujo Montalvao JA, Novaes RH, de Sa VM, Monteiro de Carvalho DB, Matuck T (2011) Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:915\u2013920","journal-title":"Pediatr Nephrol"},{"key":"3963_CR53","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1007\/s00467-017-3718-0","volume":"32","author":"K Kamei","year":"2017","unstructured":"Kamei K, Ishikura K, Sako M, Aya K, Tanaka R, Nozu K, Kaito H, Nakanishi K, Ohtomo Y, Miura K, Takahashi S, Morimoto T, Kubota W, Ito S, Nakamura H, Iijima K (2017) Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximab. Pediatr Nephrol 32:2071\u20132078","journal-title":"Pediatr Nephrol"},{"key":"3963_CR54","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Guerin V, Lapillonne H, Deschenes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2014follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083\u20131089","journal-title":"Nephrol Dial Transplant"},{"key":"3963_CR55","first-page":"993","volume":"41","author":"P Hari","year":"2004","unstructured":"Hari P, Bagga A, Mantan M (2004) Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome. Indian Pediatr 41:993\u20131000","journal-title":"Indian Pediatr"},{"key":"3963_CR56","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s00467-009-1417-1","volume":"25","author":"M Shenoy","year":"2010","unstructured":"Shenoy M, Plant ND, Lewis MA, Bradbury MG, Lennon R, Webb NJ (2010) Intravenous methylprednisolone in idiopathic childhood nephrotic syndrome. Pediatr Nephrol 25:899\u2013903","journal-title":"Pediatr Nephrol"},{"key":"3963_CR57","first-page":"650","volume":"29","author":"H Zhang","year":"2016","unstructured":"Zhang H, Wang Z, Dong LQ, Guo YN (2016) Children with steroid-resistant nephrotic syndrome: long-term outcomes of sequential steroid therapy. Biomed Environ Sci 29:650\u2013655","journal-title":"Biomed Environ Sci"},{"key":"3963_CR58","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/ndt\/gfm092","volume":"22","author":"JH Ehrich","year":"2007","unstructured":"Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J (2007) Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated. Nephrol Dial Transplant 22:2183\u20132193","journal-title":"Nephrol Dial Transplant"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3963-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3963-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T00:28:29Z","timestamp":1661387309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3963-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["3963"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3963-x","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Georges Desch\u00eanes declares that he has no conflict of interest in the field of the paper. Claire Dossier and Julien Hogan received a grant from D\u00e9l\u00e9gation de la Recherche Clinique for randomized control trials in patients with Idiopathic Nephrotic Syndrome (PHRCI-15-015 and PHRCN-16-0547, respectively).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}